License Agreement (Details Narrative) - USD ($) $ in Millions |
1 Months Ended | |
|---|---|---|
Apr. 08, 2021 |
Jun. 30, 2025 |
|
| Pfizer License Agreement [Member] | ||
| Payment for upfront fees | $ 5.0 | |
| Pfizer License Agreement [Member] | Common Stock [Member] | ||
| Issuance of common stock shares to Pfizer pursuant to an Equity Grant Agreement | 349,406 | |
| License Agreement [Member] | ||
| Payment on milestone event one | $ 5.0 | |
| Research and development expense | $ 5.0 | |
| License Agreement [Member] | Maximum [Member] | ||
| Aggregate value of milestone events | $ 335.0 |